MTOR and cancer: To confirm the interaction between the tumour‐promoting effect of 12‐LOX in the development of cancer phenotype and the activation of the PI3K/AKT/mTOR pathway, the latter pathway was suppressed with inhibitors and the cancer‐associated phenotype was further examined.